1337 related articles for article (PubMed ID: 33302541)
1. Comprehensive Review on Alzheimer's Disease: Causes and Treatment.
Breijyeh Z; Karaman R
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302541
[TBL] [Abstract][Full Text] [Related]
2. Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?
McLimans KE; Clark BE; Plagman A; Pappas C; Klinedinst B; Anatharam V; Kanthasamy A; Willette AA
Antioxid Redox Signal; 2019 Sep; 31(8):572-578. PubMed ID: 31088292
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
4. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of Alzheimer's Association with Related Proteins: Pathological Role and Therapeutic Significance.
Kumar D; Sharma A; Sharma L
Curr Neuropharmacol; 2020; 18(8):674-695. PubMed ID: 32172687
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development.
Dave BP; Shah YB; Maheshwari KG; Mansuri KA; Prajapati BS; Postwala HI; Chorawala MR
Cell Mol Neurobiol; 2023 Nov; 43(8):3847-3884. PubMed ID: 37725199
[TBL] [Abstract][Full Text] [Related]
7. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
Suzuki K; Iwata A; Iwatsubo T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
[TBL] [Abstract][Full Text] [Related]
8. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
Takeda S
Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
[TBL] [Abstract][Full Text] [Related]
9. Anti-amyloid treatments in Alzheimer's disease.
Sapra M; Kim KY
Recent Pat CNS Drug Discov; 2009 Jun; 4(2):143-8. PubMed ID: 19519562
[TBL] [Abstract][Full Text] [Related]
10. Understanding the cause of sporadic Alzheimer's disease.
Zetterberg H; Mattsson N
Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
[TBL] [Abstract][Full Text] [Related]
11. Toward an early diagnosis and treatment of Alzheimer's disease.
Nordberg A
Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
[TBL] [Abstract][Full Text] [Related]
12. Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.
Bateman RJ; Klunk WE
Neurotherapeutics; 2008 Jul; 5(3):381-90. PubMed ID: 18625449
[TBL] [Abstract][Full Text] [Related]
13. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.
Monteiro AR; Barbosa DJ; Remião F; Silva R
Biochem Pharmacol; 2023 May; 211():115522. PubMed ID: 36996971
[TBL] [Abstract][Full Text] [Related]
15. [Development of Disease-modifying Therapy for Alzheimer's Disease].
Akiyama H
Brain Nerve; 2016 Apr; 68(4):463-72. PubMed ID: 27056864
[TBL] [Abstract][Full Text] [Related]
16. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
18. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
Madav Y; Wairkar S; Prabhakar B
Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
[TBL] [Abstract][Full Text] [Related]
19. Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein.
Panza F; Solfrizzi V; Frisardi V; Imbimbo BP; Capurso C; D'Introno A; Colacicco AM; Seripa D; Vendemiale G; Capurso A; Pilotto A
Aging Clin Exp Res; 2009 Dec; 21(6):386-406. PubMed ID: 20154508
[TBL] [Abstract][Full Text] [Related]
20. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]